Shaoxing Shangyu Hualun Chemical: Specializing in Organometallic Reagents to Empower Pharmaceutical and New Materials R&D

In the Hangzhou Bay Shangyu Economic and Technological Development Zone of Zhejiang Province, an enterprise that has dedicated over two decades to the R&D and production of organometallic materials continues to lead its niche with a "specialized and sophisticated" approach. Shaoxing Shangyu Hualun Chemical Co., Ltd. (hereinafter referred to as "Shangyu Hualun Chemical"), through its relentless deep cultivation of the alkyllithium and Grignard reagent sectors, has not only broken the long-standing foreign monopoly but has also successfully earned a place among the national-level "Little Giant" specialized and sophisticated enterprises, establishing itself as a standout name in China's fine chemical industry.

Focusing on Core Business: Dual Product Lines Leading the Market

Founded in February 2001, Shangyu Hualun Chemical occupies approximately 50 mu (about 3.3 hectares) of land and employs over 80 staff members, with R&D and technical personnel accounting for more than 20% of the workforce. The company has precisely targeted the high-barrier organometallic reagent market and built a dual-product portfolio centered on alkyllithium series and Grignard reagent series. Its products encompass over 30 varieties, including n-butyllithium, sec-butyllithium, tert-butyllithium, methylmagnesium chloride, isopropylmagnesium chloride, and diethylzinc, which are widely applied in pharmaceutical intermediates, liquid crystal materials, polymer materials, and organic synthesis reagents.

Among these, the company's tert-butyllithium product, developed after five years of dedicated R&D efforts, achieves a purity of over 99.5%, with all technical specifications reaching internationally advanced levels, filling a domestic market gap. From 2023 to 2024, Shangyu Hualun Chemical captured domestic niche market shares of 55.44% and 30.57% for high-purity alkyllithium series products, firmly ranking among the industry leaders. Its Grignard reagents command a market share of over 40% in the pharmaceutical intermediates sector, with products exported to numerous countries and regions worldwide.

1. Alkyllithium Series (Flagship Core Products)

Products include n-butyllithium, sec-butyllithium, tert-butyllithium, isobutyllithium, n-hexyllithium, trimethylsilylmethyllithium, and methyllithium, with an annual production capacity of 400 tons. As essential strong-base reagents for pharmaceutical chiral synthesis and polymer polymerization, these products feature precise control over moisture and impurity content, with a comprehensive concentration gradient (0.5M–2.5M) to suit innovative pharmaceutical intermediates and lithium battery new material synthesis. The company achieves a leading domestic production scale with batch-to-batch stability comparable to imported reagent standards.

2. Grignard Reagent Series

Products include methylmagnesium chloride, isopropylmagnesium chloride, vinylmagnesium chloride, methylmagnesium bromide, and others. As fundamental nucleophilic reagents for carbon-carbon bond formation, they are widely used in the synthesis of antiviral, lipid-lowering, and antitumor active pharmaceutical ingredients (APIs). Customizable specifications in different solvents and molar concentrations are available, with strict control over impurity metal ions to meet GMP raw material access requirements for pharmaceutical companies.

3. Organozinc and Supporting Fine Reagents

Products include diethylzinc, diethylaluminum chloride, lithium chloride, lithium methoxide, and diisobutylaluminum hydride. Diethylzinc, serving as a specialized catalyst for semiconductor thin-film deposition and pesticide synthesis, features high purity and extremely low moisture content, filling the domestic gap in stable large-scale production of high-end organozinc compounds. Additionally, the company supplies flucytosine pharmaceutical intermediates, extending downstream capabilities in the pharmaceutical supply chain.

Technology-Driven Enterprise: Innovation Forging Core Barriers

Shangyu Hualun Chemical has always regarded technological innovation as the lifeblood of its business. The company houses a provincial-level high-tech enterprise R&D center and a municipal-level corporate technology R&D center, and has established deep industry-university-research partnerships with Zhejiang University of Technology, University of South China, and Shaoxing University. To date, the company has filed over 40 patent applications and has been granted 10 invention patents and 18 utility model patents, including key core technologies such as "a packed tower for synthesizing organolithium-magnesium complex catalysts."

Through continuous optimization of production processes, the comprehensive yield of the company's alkyllithium products has reached 92%, exceeding the industry average by 7 percentage points. In 2022, the company's newly built project with an investment of RMB 120 million, designed for an annual output of 3,900 tons of Grignard series products, commenced production smoothly. The entire process employs a DCS automated control system, achieving precise production control and significant efficiency improvements.

Quality First: An Industry Benchmark in Name and Reality

Backed by exceptional product quality and sustained innovation capabilities, Shangyu Hualun Chemical has obtained multiple international certifications, including ISO 9001 (Quality Management System), ISO 14001 (Environmental Management System), and ISO 45001 (Occupational Health and Safety Management System). The company has been consistently listed among Shangyu District's Top 100 Industrial Comprehensive Strength Enterprises and Top 100 Taxpayers for many consecutive years. It has also received numerous prestigious honors, including National High-Tech Enterprise, Zhejiang Provincial Specialized and Sophisticated SME, National-Level Specialized and Sophisticated "Little Giant" Enterprise, Shaoxing Municipal Green Factory, and District-Level Hidden Champion.

Corporate Development Vision

Adhering to the business philosophy of "scientifically innovating and precisely crafting metal reagents to empower pharmaceutical and material innovation," Shaoxing Shangyu Hualun Chemical leverages over two decades of technical expertise in organic synthesis reagents, a standardized explosion-proof production base in Shangyu, and a dual-line global digital service platform. The company continues to expand its portfolio of ultra-high-purity electronic-grade alkyllithium and specialty organozinc catalysts, while iterating low-solvent-recovery and anhydrous/anaerobic intelligent production lines. Looking ahead, Shangyu Hualun Chemical is committed to consolidating its leading position in China's high-end organometallic reagent market and aspires to become a trusted one-stop customized supplier of highly active synthesis reagents for the global pharmaceutical and new materials industries, contributing to the high-quality, self-reliant development of the fine chemical and innovative pharmaceutical sectors.

Enterprise Contact Information

Address: No. 1, Jing 11th Road, Shangyu Economic and Technological Development Zone, Hangzhou Bay, Zhejiang Province, China

ChemNet Shop: www.chemnet.com/ChinaSuppliers/14648/

Tel: +86-575-82732398;+86-13858535283

Email: xchl@hualun-chem.com